美国 · 平台与数据 · Finviz

FocalTherics to Announce Third Quarter 2026 Financial Results on November 5, 2026

来源：Finviz · 美国 3 天前

AUSTIN, Texas, Oct. 22, 2026 (GLOBE NEWSWIRE)-- FocalTherics (Nasdaq: FOCL) (the “Company”), a global leader in robotic focal therapy, today announced that it will release its…

在 Finviz 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (finviz.com)

FocalTherics to Announce Third Quarter 2026 Financial Results on November 5, 2026

推荐阅读

Vanguard S&P 500 ETF Long-Term Outlook: What Historical Trends Suggest for Patient Investors

Oppenheimer reiterates Amgen stock rating on cancer drug data

Dr. Reddy's Laboratories Ltd (NYSE:RDY) Stock Has Consensus Target Price of $492.90

Roche lung cancer drug extends survival by nearly six months in late-stage trial

‘She’s living the dream’: My stepmother said I can buy my childhood home for $850,000. Is she taking advantage of me?

Samsung’s Galaxy Fit 4 could undercut Fitbit by $120

FocalTherics to Announce Third Quarter 2026 Financial Results on November 5, 2026

分享

推荐阅读

Vanguard S&P 500 ETF Long-Term Outlook: What Historical Trends Suggest for Patient Investors

Oppenheimer reiterates Amgen stock rating on cancer drug data

Dr. Reddy's Laboratories Ltd (NYSE:RDY) Stock Has Consensus Target Price of $492.90

Roche lung cancer drug extends survival by nearly six months in late-stage trial

‘She’s living the dream’: My stepmother said I can buy my childhood home for $850,000. Is she taking advantage of me?

Samsung’s Galaxy Fit 4 could undercut Fitbit by $120